I.V. Dressing Market Growth Is Attributed to the Increasing Prevalence of Bloodstream Infections

IV dressing is a transparent dressing used to secure objects, such as I.V. sites or Catheters, to the insertion point and can also be used as secondary dressings. This type of dressing maintains a moist that is necessary for wound healing. Thus, growth of the I.V. dressing market is mainly driven by the increasing incidence of infections such as catheter-related bloodstream infection (CRBSI), central line associated bloodstream infection (CLABSI), other infections. According to the Centers for Disease Control and Prevention (CDC), central line-associated bloodstream infections result in thousands of deaths each year and billions of dollars in added costs to the U.S. healthcare system.

CLABSI is a highly prevalent problem in the intensive care unit (ICU). In the United States, the CLABSI rate in intensive care units (ICU) is estimated to be 0.8 per 1000 central line days. Moreover, an estimated 250,000 bloodstream infections occur annually, and most are related to the presence of intravascular devices. This in turn is expected to increase the demand for IV dressing in the United States, driving the growth of the I.V. dressing market. I.V. (Intravenous) is the fastest route to deliver blood transfusions, fluids, medications, and others in patients.

Request For Sample Copy of I.V. Dressing Market@ https://www.coherentmarketinsights.com/insight/request-sample/3182

It is used in patients with physical debility, to maintain electrolyte balance, for fluid replacement, and is also used to deliver fluids, medications, etc.

IV dressing acts as a quick fixation dressing to secure intramuscular catheters, the I.V. cannula, and other percutaneous devices. It is a translucent or transparent type of dressing made up of polyurethane collated films and adhesive material, it prevents bacterial infection and prevents moisture buildup to protect against germs and dust. Thus, there is an increasing demand for IV dressing worldwide.

For example, in July 2018, 3M launched Tegaderm Antimicrobial I.V. Advanced Securement Dressing and Tegaderm Antimicrobial Transparent Dressing to enhance its PIV maintenance solution offerings and help reduce infection risk.

Buy Now and Get Instant Discount of USD 2000 for Premium Report:
https://www.coherentmarketinsights.com/promo/buynow/3182

Moreover, growth of the I.V. dressing market can be attributed to the increasing prevalence of chronic kidney diseases (CKD) worldwide, increasing number of dialysis procedures, as they require central venous catheter, and increasing number of surgeries that mostly requires I.V. dressing.

According to CDC, more than one in seven, that is 15% of US adults or 37 million people, are estimated to have CKD. Moreover, there are now more than 7,500 dialysis clinics in the United States. However, there are some complications associated with I.V. dressing, such as discomfort, swelling, nausea, and others. This in turn is expected to restrain the growth of the I.V. dressing market.

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.